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ABSTRACT
OPTIMAL COUNSELING AND THE UTILITY OF IMAGING PARAMETERS IN
PATIENTS WITH IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS
Harry E. Subramanian, Charles C. Matouk, and Amit Mahajan. Departments of
Neurosurgery and of Radiology & Biomedical Imaging, Yale School of Medicine, New
Haven, Connecticut.

It is very difficult to counsel patients who are suspected to have idiopathic normal pressure
hydrocephalus (iNPH) due to the variability in diagnostic criteria and clinical
presentations, as well as the difficulty in evaluating prognosis. This two part study was
conducted in order to identify ways to improve the counseling of patients with iNPH. A
qualitative analysis of patient experience with iNPH and shunting was initially performed.
This was followed by an imaging analysis to identify predictors of outcome after shunt
surgery.

A cohort of patients with iNPH who were shunted at a single institution were identified
retrospectively and interviewed to explore patient experience. Interview transcripts were
analyzed using the principles of grounded theory, which yielded seven overarching themes.
From these themes, it was concluded that patients: suffer from a long preoperative course,
desire improvement in functional independence, are not affected by the inability to provide
a prognosis associated with shunt surgery, are confounded by comorbid conditions, and
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receive heavy influence from family members and caregivers. These conclusions can be
incorporated by physicians to improve patient counseling.

Features on the brain imaging of the same cohort of patients were reviewed retrospectively
and compared with patient-reported subjective binary outcomes obtained from the patient
interviews. A few imaging features were found to be possible predictors of outcome after
shunting. The presence of focally dilated sulci may be a predictor of gait improvement, and
a larger Evans’ index, larger third ventricular diameter, and larger callosal height, may all
be predictors of cognitive improvement. However, there is significant discordance in the
literature regarding the predictive value of imaging features. The utility of imaging
parameters in patient counseling remains limited until more consistent results can be
produced.
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INTRODUCTION AND BACKGROUND
Introduction
Normal pressure hydrocephalus (NPH) is a syndrome that presents with dilated lateral
ventricles and clinical symptoms involving gait, cognition, and urination, as well as a lack
of elevated cerebrospinal fluid (CSF) pressure or visible CSF obstruction. The etiology of
this condition is poorly understood, but thought to represent a problem of CSF dynamics.
In cases where some condition such as meningitis or subarachnoid hemorrhage precedes
the onset of NPH, the syndrome is referred to as secondary NPH. When there is no
preceding condition, it is considered idiopathic normal pressure hydrocephalus (iNPH).
The prevalence of iNPH in patients greater than 65 years old has been calculated to be
1.3%, with an annual incidence of 120 cases per 100,000 people (1). However, these
calculations are limited because there is no standard consensus of how to diagnose iNPH.

Typical diagnostic criteria utilized by physicians include older age (greater than 60 years),
dilated lateral ventricles on imaging, and the classical symptom triad of gait disturbance,
cognitive impairment, and urinary incontinence (2). The gait in patients with iNPH can be
described as having low speed, short stride length, wide base, and increased double support
time (3). The cognitive deficits seen in patients with iNPH include diminished working
memory, diminished psychomotor speed, and decreased attention (4). The urinary
symptoms seen in patients with iNPH usually include overactive bladder, which can
present in patients as urge incontinence or increased nocturnal urinary frequency (5).
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Diagnosis of iNPH
The formal diagnostic criteria currently in use come from two major guidelines. The
international guidelines published in 2005 characterize the diagnosis of iNPH into three
categories: probable, possible, or unlikely (6). The more recent Japanese guidelines
published in 2012 use symptomatic and imaging criteria to also characterize the diagnosis
of iNPH into three categories: possible, probable, or definite (2). Possible iNPH can be
diagnosed when a patient meets all of five major features: age greater than 60 years, at least
two symptoms of the classical symptom triad, ventricular dilation with an Evans’ index
greater than 0.3, no other disease that can explain the patient’s symptoms, and no preceding
condition that may cause ventricular dilation. Many additional features which would
support a diagnosis of possible iNPH include: a slow progression of symptoms, gait
disturbance being the most prevalent feature with a shuffling and unstable gait, and
enlarged Sylvian fissures and basal cistern. A diagnosis of possible iNPH can be upgraded
to probable iNPH if there is a measured CSF pressure less than 200 mm H2O with normal
CSF content, and the patient also has at least one of the following features:
disproportionately enlarged subarachnoid space with narrow sulci over the high convexity
on imaging observed concurrently with gait disturbance, improvement of symptoms after
a CSF tap test, or improvement of symptoms after a CSF drainage test. A diagnosis of
definitive iNPH can be given only with observation of clinical improvement following CSF
shunt placement.
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Despite the presence of these guidelines, it remains difficult to diagnose iNPH when
patients do not obviously meet all of the stated criteria. The clinical presentation of iNPH
can overlap with a number of conditions, which can make it very difficult for the physician
to arrive at a diagnosis (7). The symptoms of iNPH are often attributed to other neurological
disorders such as Parkinson’s disease (8) or Alzheimer’s disease (9), or vice-versa.

Unfortunately, the only means to provide a definitive diagnosis of iNPH is to observe
clinical improvement following CSF shunt placement. The CSF removal test (sometimes
referred to as the CSF tap test) is a commonly used method to predict patient improvement
from shunting. This test involves draining a small volume, approximately 50 mL, of CSF
through a lumbar puncture and observing the patient for subsequent clinical improvement.
When used to predict improvement from shunting, the CSF removal test has demonstrated
an average sensitivity of 58% (26-87%) and specificity of 75% (33-100%) (10). Therefore,
even with a positive tap test, it remains difficult to predict which patients will improve with
shunt placement.

Treatment of iNPH
The preferred treatment for iNPH is surgical placement of a ventriculoperitoneal shunt that
is used to divert CSF flow. The Japanese guidelines suggest shunting as a treatment for
probable iNPH but not possible iNPH (2). However, the authors also indicate that this
guideline should be used in combination with the clinical judgment of the treating
physicians. As a result, there is significant variability regarding which patients are
candidates for shunt placement, and the decision-making process includes a discussion
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with the patient about the possibility of improvement in quality of life. While shunting can
provide significant benefits, it is not without complications. These include serious adverse
events such as shunt obstruction, bowel perforation, and subdural hematoma, as well as
less serious adverse events such as headache and subdural effusion (11).

Outcomes after CSF Shunting
The Japanese guidelines compile a summary of outcomes after shunting that have been
reported in the literature. In the three to six months after shunt placement, there is a reported
improvement in 64-96% of patients. At one year after shunt placement, improvement is
seen in 41-95% of patients. In the three to five years after shunt placement, improvement
is seen in 28–91% of patients (2).

There is currently no universally adopted method to measure the outcomes after shunting
in patients with iNPH. Numerous tests are available to evaluate the three main symptoms
of gait disturbance, cognitive impairment, and urinary dysfunction. The Timed Up and Go
test can measure gait function (12), the Mini-Mental State Examination can measure
overall cognitive function (13), the Frontal Assessment Battery can evaluate frontal lobe
function (14), and the International Consultation on Incontinence Questionnaire is a selfadministered questionnaire that can be used to assess urinary dysfunction (15). In addition,
an iNPH Grading Scale has been developed, which is used to separately assess cognitive
impairment, gait disturbance and urinary symptoms. Each of the symptoms is assessed by
physician observation as well as patient interview, and given a score on an ordinal scale
between 0 and 4 (16). Another option to measure outcomes is the modified Rankin scale,
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which is a well-established but non-specific test primarily used to grade the overall clinical
status of patients recovering from stroke. This test scores patients on an ordinal scale from
0 to 5 (17). The Japanese guidelines recommend use of the modified Rankin scale as the
primary method to assess functional impairment, and use of the iNPH Grading Scale to
assess each individual symptom (2).

While these outcomes provide an objective assessment of the symptomatic response to
shunting, they do not provide a complete measure of the patient’s quality of life. Because
shunt placement is an elective procedure that is used to improve overall living condition,
it is important to identify if shunting has provided any noticeable benefit to the patient. To
accomplish this, subjective patient-reported outcomes can be used to find which patients
perceive an improvement in quality of life after surgery. The Impact on Participation and
Autonomy questionnaire can be used to measure patient-reported outcomes related to eight
general domains of daily life (18). Furthermore, the experiences of the long-term caregiver
for the patient can be measured by the caregiver burden scale, which is a subjective
questionnaire that explores 5 categories of caregiver burden (19). A recent study of 37
iNPH patients found that self-reported quality of life six months after shunt surgery was
increased in 86% of patients while only 65% of patients demonstrated symptomatic
improvement measured using objective scales. Half of the patients who showed no
objective symptomatic improvement reported an improvement in quality of life (20). This
suggests that there are important outcomes that are not captured by the objective symptom
scales currently in use.
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Objectives
With the large number of diagnostic criteria for iNPH, the numerous possible clinical
presentations of patients, and the tremendous range of reported outcomes, it is very difficult
to counsel patients who are suspected to have iNPH regarding their prognosis and shunt
surgery. This study was undertaken in order to identify how physicians can improve
counseling of patients with iNPH. To answer this question, two major endeavors were
attempted. In the first study, a qualitative analysis was conducted with patients who had
undergone shunt surgery for iNPH. This was done in order to gain information about
patient perspectives and experiences regarding their illness and the shunt surgery. Long
term patient-reported subjective outcomes after shunting were obtained as well. In the
second study, patient preoperative imaging features were evaluated and measured
retrospectively. This was done in order to identify any potential associations between
imaging features and patient outcome after shunting, with the hope that this information
could be used to help counsel future patients.
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STATEMENT OF PURPOSE
Specific Aims

•

To improve the counseling of patients with iNPH.

•

To study the subjective experience of patients undergoing the diagnostic workup
and surgical treatment for iNPH.

•

To identify the challenges and unmet needs of patients with iNPH in order to
improve patient outcomes and satisfaction.

•

To investigate the associations between imaging parameters and outcome after
shunt surgery in patients with iNPH.
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QUALITATIVE STUDY OF INPH
INTRODUCTION

It is very challenging to counsel patients who are suspected to have iNPH regarding their
prognosis and the possibility of shunt surgery. This is due to diagnostic difficulty arising
from the tremendous variability in the diagnostic criteria for iNPH and in the clinical
presentations of patients. It is difficult to predict both who will derive clinical benefit from
shunt surgery, and the extent of improvement that may be seen with shunting. The
outcomes after shunt surgery reported in the literature are variable. One set of guidelines
reports gait is improved in 58-90% of patients, cognition is improved in 29-80% of patients,
and urinary symptoms are improved in 20-82.5% of patients (2). Another set of guidelines
has reported overall subjective improvement in 96% of patients, however studies designed
to produce high level evidence supporting shunting have not yet been produced (21).

Understanding how patients experience such a complicated illness could allow physicians
to better care for their patients. Qualitative research is useful to gain insight into patient
perceptions and experiences. It can be used to explore social and emotional phenomena
and to provide contextual information, which can be used to develop conceptual
frameworks or theories (22, 23). Subjective questioning can be used to identify the impact
of symptoms on patient quality of life, patient thoughts and concerns regarding shunt
placement, patient motivations, and what benefits patients perceive from shunt surgery.
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This information could be used to help physicians counsel patients who may be candidates
for shunt placement, and also to identify patients who may benefit from shunt placement
without showing signs of objective improvement. A study of the subjective experience of
patients undergoing diagnostic workup and surgical treatment for iNPH has not been
previously reported. This study was done to explore patients’ experience with iNPH and
shunt surgery, in order to investigate how patients make decisions and how they benefit
from shunting, and to identify how patient experience could be improved.
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METHODS

A qualitative study was conducted to examine patient experience with iNPH and shunt
surgery. A consecutive series of patients who were diagnosed with iNPH and underwent
ventriculoperitoneal shunt surgery between January 2012 and March 2016 at a single
institution were retrospectively reviewed from a prospectively maintained database. A total
of 64 living patients were identified to participate in the study. All patients were treated by
one neurosurgeon and had lived for at least one year with their shunt at the time of their
interview. These patients were enrolled to participate by telephone and provided
information about the study. Patients who agreed to participate in the study were
subsequently interviewed by telephone. All interviews were conducted by one investigator.
Family members and other caregivers of patients were encouraged to participate when
possible.

A semi-structured interview was conducted using a written template of interview questions
where the interviewer had freedom to deviate from the template as needed. The interview
template was modified as new themes developed throughout the study. The final interview
template is shown in the Appendix. Interviews were recorded and transcribed verbatim.
The transcripts were analyzed using open and axial coding, based on the principles of
grounded theory (24). The analysis involved organizing the data into different overarching
themes. Data analysis was conducted simultaneously as the interviews were conducted.
Saturation of themes was reached after interviewing 31 patients.
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Patient demographic data and information regarding patient preoperative course were
collected through retrospective review of the medical record. Patient self-reported
subjective outcomes were assessed in the interview by asking patients specifically if they
had any improvement with each of gait, cognitive, and urinary symptoms. Informed
consent was obtained from all participants in this study. This study was approved by the
Yale University Institutional Review Board.
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RESULTS

Patient Information
A total of 64 consecutive patients were eligible to participate, of which 40 volunteered to
partake in the study and were interviewed. Saturation of themes was reached after the first
31 interviews, and these 31 patients comprise the study population. Patient characteristics
including medication use and select comorbid conditions are summarized in Table 1.
Patient symptoms related to iNPH as well as postoperative outcomes are summarized in
Table 2. The median age was 77 years (range 64 - 90). The median duration between shunt
surgery and interview was 30 months (range 16 - 56). Cardiovascular disease was present
in 84% of patients, diabetes mellitus in 32%, and a history of stroke in 23%. At the time of
diagnosis of iNPH, gait disturbance was the most common symptom and present in 100%
of patients, followed by urinary incontinence in 81%, and cognitive impairment in 71%.
After shunt surgery, 74% of patients reported improvement in gait, 44% reported
improvement in urinary incontinence, and 45% reported cognitive improvement.
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Table 1. Patient characteristics (n=31)
Characteristic
Age
Median
Range
Sex
Male
Female
Race
Caucasian
African-American
Asian
Medications
Anti-hypertensive
Lipid lowering
Anti-platelet or anti-coagulation
Anti-diabetic
Anti-psychotic
Anti-depressant
Benzodiazepine
Anti-Parkinson’s disease A
Cognition enhancing B
Comorbid cardiovascular disease
Any
Hypertension
Hyperlipidemia
Coronary artery disease
Comorbid neurological disease
Stroke
Alzheimer’s disease
Parkinson’s disease
Other comorbid condition
Diabetes mellitus
A
B

Number of Patients (%)
77 years
64 - 90 years
14 (45%)
17 (55%)
29 (94%)
1 (3%)
1 (3%)
23 (74%)
19 (61%)
17 (55%)
10 (32%)
4 (13%)
15 (48%)
8 (26%)
4 (13%)
6 (19%)
26 (84%)
21 (68%)
15 (48%)
8 (26%)
7 (23%)
0 (0%)
3 (10%)
10 (32%)

includes carbidopa-levodopa and rasagiline
includes rivastigmine, donepezil, and memantine
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Table 2. Patient preoperative symptoms and postoperative outcomes (n=31).
Characteristic
Preoperative symptoms
Gait disturbance
Cognitive impairment
Urinary incontinence
Duration of preoperative symptoms
≤ 1 year
> 1 year
Time between surgery and interview
Median
Range
Patient reported outcome at interview
Gait improvement
Cognitive improvement
Urinary improvement
Other interview information
Satisfied with shunt surgery
Would recommend surgery to another patient
Caregiver participated in interview
A
B

Number of Patients (%)
31 (100%)
22 (71%)
25 (81%)
21 (68%)
10 (32%)
30 months
16 - 56 months
23 (74%)
10 (45%A)
11 (44%B)
25 (81%)
28 (90%)
12 (39%)

represents 10 out of 22 patients
represents 11 out of 25 patients

Thematic Analysis
Analysis of the patient interviews produced seven overarching themes. Examples of
responses from patient interviews are shown in quotations.

1. Long preoperative course and diagnostic uncertainty are a major source of morbidity.

Patients often had a long preoperative course that involved consultation with multiple
physicians. Ten (32%) patients reported having symptoms for greater than one year before
having shunt surgery. In these cases, there was diagnostic uncertainty, and patients may
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have been incorrectly diagnosed with Parkinson’s disease or with another cause of
dementia. Eventually a neurologist or primary care physician would suggest the diagnosis
of iNPH and refer the patient to a neurosurgeon for further evaluation.

“They didn’t really know what was wrong with me. This went on for a long time and
nobody had any clue. I went to three different hospitals. I finally went back to my primary
doctor and he suggested I go to another neurologist outside the hospital.”

“We took her to different doctors and people and medical staff, trying to find out what was
wrong. Everybody kept telling me it was just her behavior. No one gave me sound advice.”

As a result, patients often presented to the neurosurgeon frustrated and desperate for
answers. Patients suggested that the excessive medical visits and testing they endured were
more difficult than the shunt surgery itself.

“They were doing a lot of tests and he just kept getting worse. He went from this doctor to
that doctor.”

Some patients expressed disappointment with the delay in time from the onset of their
symptoms to their shunt surgery. They believed quicker intervention would have resulted
in a better postoperative outcome.

16
“I wish it had been caught sooner. I feel like if it had been caught sooner, maybe I would
have benefitted more.”

2. The decision to have shunt surgery is very easy to make.

Patients did not report any difficulty in deciding whether or not to have shunt surgery. Most
were willing to have the surgery as soon as it was presented as an option by the
neurosurgeon. Patients reported that they were unwilling to continue with their symptoms
or decline in function, and some viewed proceeding with no intervention as unacceptable.
As a result, even in cases where the surgeon could not state that a good outcome was likely
to occur, patients did not have difficulty in deciding to procced with shunt surgery.

“I had no choice. I couldn’t function. It was as bad as I described to you. So, I really had
no choice. I just wanted to see if my condition could be corrected.”

Patients relied on the neurosurgeon to tell them what to do. They stated that a
recommendation to proceed with shunt surgery made by the neurosurgeon had a large
influence.

“I just took his [the neurosurgeon’s] word that I needed it done.”

3. The main reason to have shunt surgery is to gain improved mobility and independence.
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All patients expressed their primary desire was to be independent in daily functioning and
to be able to move around without assistance from another person. A common aspiration
was to walk without a fear of falling down. Improvement in gait symptoms was always
more important than improvement in cognitive or urinary symptoms. Patients used their
functional status at a time they perceived to be before the onset of iNPH as a reference and
goal for their desired improvement after surgery. Patients also desired not to be a burden
on their family or caregivers.

“I missed being independent. I don’t like to have to depend on people to do anything for
me.”

“I wanted to be able to live my life without my daughter shuffling me all over the place.”

4. Variable levels of anxiety surrounding shunt surgery are reported.

There was a wide range of anxiety reported by patients. Some had significant anxiety, some
had minimal anxiety, and others did not report any anxiety. Patients with anxiety attributed
it to multiple causes, including anxiety that comes with any operation, the serious
connotation of “brain surgery”, or simply being in the hospital.

“I was anxious because it was brain surgery and I had never experienced brain surgery or
known anyone who had had brain surgery.”
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Patients stated their anxiety was alleviated when there was good communication with the
neurosurgeon. Patients who did not report anxiety often cited their experience with
previous surgeries.

“He had open heart surgery before. He joked all the way to the OR [operating room].”

Others described benefitting from their interactions with other iNPH patients who had
already been shunted.

“I spoke to the daughter of someone who had a shunt put in and she reassured me that it
really wasn’t a big deal to have the shunt put in.”

Patients did not report anxiety due to any uncertainty regarding the potential outcomes after
surgery.

5. Difficulty describing any improvement after surgery arises due to symptoms from other
comorbid conditions.

Patients had difficulty isolating the effect of iNPH and shunt surgery from their entire
clinical picture. Patients reported fractures, osteoarthritis, and other musculoskeletal
injuries that interfered with gait and mobility. Cerebrovascular accident or progression of
dementia interfered with cognition. And recurrent urinary tract infections and prostate
disease interfered with urination.
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“I’m fine with my walking except for the fact that I have two bad knees. I have used a cane
occasionally because of my knees bothering me.”

“Immediately after the surgery she was clearer but it wasn’t great. But then after that, the
Alzheimer’s started to show more so it’s hard to tell if the shunt surgery made a big
difference.”

“I had prostate cancer. With that I have uncontrollable urine.”

Patients who reported improvement in their symptoms and functioning often attributed any
persistent postoperative symptoms to other comorbid conditions rather than to their iNPH.

“He uses a walker and that is only because of the arthritis.”

In some cases, comorbid conditions caused much more distress than anything associated
with iNPH or shunting.

6. Patients stand by their decision to have shunt surgery regardless of the outcome.

The satisfaction patients reported after having surgery was very variable and did not seem
related to the degree of improvement. Some patients were satisfied with partial recovery of
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function while others were happy with minimal improvement, and others expected a full
recovery to preoperative function.

“Any improvement we thought was acceptable no matter what.”

“With my walker, I can go wherever I want, but it’s a pain in the neck. Other than that, I’ve
come to live with it and it doesn’t bother me.”

Regardless of what outcome patients had after shunt surgery, they all expressed satisfaction
with their neurosurgeon. Patients attributed their clinical improvement to the effectiveness
and skill of their surgeon, but did not blame the surgeon for poor outcomes. Instead patients
who were not satisfied attributed their lack of improvement to the natural state of their
illness.

“I am not at all unhappy about the way things went. I am very grateful for the surgeon
trying everything he could for me.”

“I’m not saying the surgeon did anything wrong. The point is whatever procedure he did
was not effective in any way.”

Patients stated desirable qualities in their neurosurgeon included a calm demeanor,
confidence, good communication, availability, intelligence, and an accommodating
manner.
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“He [the neurosurgeon] did everything well. He talks to you, he listens to you, he follows
up with you, and he helps you out when you come back after the surgery.”

Patients remained confident that having shunt surgery was the correct decision to make,
regardless of their outcome afterwards. Many expressed their hope for improvement and
the desire to take a chance even without a guarantee of improvement after surgery.

“I would always have regretted it if we didn’t have the surgery, but I had hoped that the
outcome would be better.”

“I would have done the surgery no matter what because I wanted to be able to walk.”

Patients were willing to speak to other patients with iNPH who may be considering shunt
surgery. Most patients would recommend shunt surgery to someone else. Some patients
reported having already counseled other patients with iNPH.

“We have a neighbor who had the same exact condition [iNPH]. I told her everything that
happened with me, and I gave her a lot of support.”

“I would recommend the surgery. In fact, I have already done that. There was a patient that
was on the fence whether he was going to have it done. He wanted to talk to me, so I talked
to the guy and he ended up having the procedure.”
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7. Outside information is utilized from the internet, books, or friends and family members,
prior to shunt surgery.

Patients attempted to gather outside information in order to learn more about the diagnosis
of iNPH as well as details about the shunt surgery. Most often patients searched for
information on the internet, however there was no specific website or online resource that
was reported as helpful. Patients also looked up information that had already been provided
to them by their doctors, using that information as a second opinion, which helped patients
feel less anxious about the surgery.

“The support group is called the hydrocephalus association. It gave me some more
information before the surgery about what is hydrocephalus, what causes it, how it’s
treated, and the symptoms of the condition.”

“We were all over the internet and Google. We googled everything, even the information
the surgeon gave us before the surgery.”

Family members, caregivers, and friends played a large role in counseling patients about
their diagnosis and shunt surgery. Patients specifically sought out the opinions of personal
contacts who had experience working in healthcare.
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“I ended up with this neurosurgeon because my friend’s daughter is an assistant professor
in your department.”

“I went and had an interview with the neurosurgeon. My daughter was with me and we
agreed that I should have it done.”
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DISCUSSION

A qualitative study of patients with iNPH undergoing shunt surgery has not been previously
reported in the literature. This study exploring iNPH patients’ experiences with their illness
and with shunt surgery produced several overarching themes. iNPH is difficult to diagnose
due to the variability in diagnostic criteria and in patient presentation. By the time patients
present to the neurosurgeon for evaluation, many have undergone an extensive
preoperative course consisting of multiple healthcare visits, diagnostic testing, and possibly
incorrect diagnoses. Uncertainty is a major cause of patient morbidity. Patients are often
frustrated, seeking answers, and desperate for any improvement. It is important to
recognize this when counseling patients regarding shunt surgery. Communication between
physicians is essential to ensure uniformity in the treatment plan and to ensure the correct
diagnoses are given, especially regarding neurologic diagnoses.

Patients described no difficulty in making the decision to proceed with shunt surgery. The
desperation felt by patients when they present to the neurosurgeon likely plays a role here.
In addition, patients may be heavily influenced by the surgeon’s recommendation, and
would have the shunt surgery if the neurosurgeon suggested it should be done. In these
instances, care must be taken to ensure patients are provided with all of the information
possible, including the comparison of risks to benefits and the difficulty of predicting
postoperative outcome.
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The primary reason for patients to have shunt surgery was to improve mobility and
independent functioning. All patients in this study experienced gait disturbance prior to
surgery. The preoperative prevalence of gait disturbance (100%), cognitive impairment
(71%) and urinary incontinence (81%) in this study is consistent with the prevalence
reported in the literature (2). The rates of gait improvement (74%), cognitive improvement
(45%), and urinary improvement (44%) in this study are consistent as well, however there
is a wide range of reported improvement in the literature.

Anxiety surrounding the shunt surgery arose from the fact that it was an invasive procedure
and from the serious connotation given to “brain surgery”. Therefore, it seems appropriate
that patients who had undergone previous surgeries reported less anxiety. Interestingly,
patients were not worried about the chance they would not improve after surgery.

It is important to acknowledge the difficulty that exists in measuring outcomes after shunt
surgery. The patient population in this study had numerous comorbid conditions including
cardiovascular and neurological diseases. This is not surprising given iNPH is a disease of
the elderly. Because of comorbidities confounding the clinical picture, it is often
impossible to isolate the effects of iNPH and shunt placement from everything that is
happening with the patient. Recommendations regarding the recognition and management
of prominent comorbidities in iNPH patients have been published by the International
Society for Hydrocephalus and Cerebrospinal Fluid Disorders (9). However, due to a lack
of clinical trials, these recommendations are based on expert consensus opinion.
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There is currently no standard method to measure patient outcomes after shunt surgery.
Some prominent methods reported in the literature include the iNPH Grading Scale (16)
and the modified Rankin scale (17). In addition the Timed Up and Go test can evaluate gait
(12), the Mini-Mental State Examination can evaluate cognitive function (13), and the
International Consultation on Incontinence Questionnaire can assess urinary symptoms
(15). Subjective physician and patient reported outcomes have also been used to assess
patient functioning and quality of life after shunting (20). In this study, subjective patientreported outcomes were assessed for gait, cognition, and urination.

Reporting outcomes can be affected by comorbidities regardless of which method is used
to assess patients. For example, in a patient with worsening gait after shunt placement, this
decline could be attributed to worsening osteoarthritis or other musculoskeletal injuries. It
may not be possible to determine the benefit from shunting, as any gains from the shunt
are overshadowed by the worsening musculoskeletal comorbidities. It is also not possible
to state if that patient’s gait would have declined more rapidly without shunt placement.
Patients are likely to report a successful shunting and attribute persistent symptoms to their
comorbid conditions. This may be because of a strong desire to feel as if the surgery was
worth doing. Caution is needed when evaluating clinical outcomes.

Overall, 81% of patients in this study said they were satisfied with the results from their
shunt surgery. However, the degree of improvement affecting patient satisfaction was
variable. Therefore, it is important to discuss in specific detail the patient’s goals prior to
shunt surgery in order to lessen instances of disappointment postoperatively. Patient
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outcome also did not correlate with satisfaction with the neurosurgeon, as patients credited
the surgeon with their improvement but did not blame the surgeon for poor outcomes. This
could be due to the strength of the doctor-patient relationship and the confidence patients
had in their surgeon. Patients also stood by their decision to have shunt surgery even when
they were not satisfied with the outcome. This is likely connected to their decision-making
process, their desperation, and their willingness to take a chance with surgery to hope for
improvement.

With the abundance of information available online and through other sources, it is not
surprising that patients would read on their own about their diagnosis and treatment. This
was primarily a tool to reduce patient anxiety, as much of the information found by patients
was already provided to them by their doctors. However, given the variation in quality
among all possible sources of available information, it is important for physicians to
discuss with patients any outside research. It is likely that seeing the same information
presented twice provided patients with reassurance and helped put them at ease. Similarly,
patients prior to shunt surgery benefitted from speaking to other patients with iNPH who
had already undergone shunt placement. Speaking to someone with firsthand experience
with shunting provided reassurance and reduced anxiety. Patients also indicated a
willingness to speak to other patients who are diagnosed with iNPH and are candidates for
shunt surgery. It is possible that facilitation of this patient-patient interaction by the
neurosurgeon may improve patient experience.
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Outside research was not reported to have much effect on the decision to have shunt
surgery. This is in contrast to counseling from family members and friends, which had a
large impact on patient decision-making. Patients often decided to have surgery after
agreement by their family members, and personal contacts influenced where patients
received their medical care. The importance of patient family members and caregivers on
patient motivations, decision-making, and clinical course cannot be overstated. Patients
routinely expressed their motivation to have shunt surgery due to their fear of imposing a
burden on their caregivers. Because of the large impact they have, family members and
caregivers should be included in the appointments and discussions when counseling
patients regarding iNPH and shunt surgery.

Limitations
This study represents the experiences of a population of patients with iNPH treated at a
single institution by a single surgeon. Due to the variability in diagnosis and treatment
guidelines for iNPH, caution should be used when translating these results to different
patient populations at different institutions. In addition, patients were recruited
retrospectively and voluntarily, and there is the possibility of associated selection bias.
Patients with iNPH who were not shunted were not included in this study and those patients
may have different experiences, which should be taken into account when applying these
results to patient counseling. There is also the potential to receive biased answers when
patients believe they are speaking to their surgeon or someone else who is providing them
with clinical care. Care was taken to encourage patients to respond freely, and the
interviews were conducted by someone who did not provide any of the clinical care for the
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patients. Interviews in this study were conducted by telephone. The preferred method for
qualitative interviewing is to conduct interviews in person, in order to utilize body language
and cues to obtain information and promote conversation. However, this was not possible
in this patient population, as many patients had difficulty with mobility and required
significant caregiver assistance to travel, and conducting interviews in person would have
placed an undue burden on the patients.
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CONCLUSIONS

Shunt surgery is the standard treatment for iNPH, and a definitive diagnosis can only be
provided postoperatively. It is difficult to predict which patients will improve after shunting
or how they will improve. Due to variable clinical presentations and difficulty predicting
outcomes, it is challenging to counsel patients with iNPH. Patients often present to the
neurosurgeon frustrated after a long preoperative course, and their desperation plays a
major role in their decision-making process. Patients are desperate to gain improved
mobility and functional independence, and are willing to take a chance with shunting
despite the inability to guarantee a successful outcome. It is important to acknowledge the
uncertainty regarding diagnosis and response to shunting when counseling patients. There
are a wide variety of methods to measure outcomes after shunt surgery. However, patients’
comorbid conditions can interfere with the ability to assess the effectiveness of the shunt.
It may be difficult to separate iNPH from the patient’s entire clinical picture. Patient family
members and caregivers play a large role in patient decision-making and clinical course.
Patients rely on these personal contacts for support and are often motivated by the desire
to not impose a burden on them. Family members and caregivers should be included when
counseling patients about iNPH and shunt surgery.
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IMAGING ANALYSIS OF INPH
INTRODUCTION

Imaging with magnetic resonance imaging (MRI) or computed tomography (CT) scanning
is an essential diagnostic as well as prognostic component in the evaluation of patients with
iNPH. The most commonly measured radiologic feature is the Evans’ index, which is a
marker of ventricular dilation, and calculated as the ratio of the maximum width of the
frontal horns of the lateral ventricles to the maximum width of the inner table of the
cranium (25). Both the international and Japanese guidelines require an Evans’ index
greater than 0.3 to diagnose iNPH (2, 6). In addition, the international guidelines
recommend evaluation for an enlargement of the temporal horns of the lateral ventricles, a
callosal angle greater than 40 degrees, the presence of periventricular lesions, and an
aqueductal or fourth ventricular flow void, to support the diagnosis of iNPH (6).

The angle of the corpus callosum is an important feature on imaging. Patients with iNPH
have been noted to have smaller callosal angles compared to healthy patients. In one study
that evaluated patients with an enlarged Evans’ index, using a threshold angle of 90
degrees, patients with iNPH could be identified with a sensitivity of 97% and specificity
of 94% (26). In addition, patients with iNPH who respond to shunting have been found in
another study to have a smaller callosal angle than those who do not respond. Using a
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threshold angle of 63 degrees allowed for prediction of shunt responders with a sensitivity
of 67% and a specificity of 65% (27).

A recently published retrospective study of 390 patients identified that a disproportion
between supra-Sylvian and Sylvian subarachnoid spaces and a smaller mean width of the
temporal horns on imaging were associated with the diagnosis of probable iNPH. However,
no radiological markers were predictive of shunt response (28). Another recently published
retrospective study of 108 patients identified that a smaller callosal angle, wider temporal
horns, and the presence of disproportionately enlarged subarachnoid space were associated
with a better outcome after shunting. However, the authors were not able to establish
threshold values for these features and therefore could not make any recommendations
regarding which patients would be better candidates for shunt placement (29).

A subset of patients with iNPH have narrowed subarachnoid spaces over the cerebral
convexity and medial surface of the cerebral hemispheres, in conjunction with enlarged
subarachnoid spaces over the Sylvian fissures. This subset of iNPH has been given the term
disproportionately enlarged subarachnoid space hydrocephalus (DESH) (11) and the
Japanese guidelines recommend classification of iNPH as DESH or non-DESH (2). Few
studies have examined the prognostic value of DESH, and the utility of DESH remains
controversial.

Although there are numerous imaging features associated with the diagnosis of iNPH, there
remains significant uncertainty regarding which features can be useful prognostic factors.

33
The variability in the measurement of patient outcomes also complicates any comparisons
made between different studies that evaluate imaging features in patients with iNPH.
Identification of imaging parameters that could be used to predict a response to CSF shunt
placement would provide great value to the treating physician. This study was done to
evaluate the preoperative imaging of patients with iNPH and to identify any associations
between patient imaging and long term patient-reported outcome after shunt placement,
with the hope of using this information to improve patient counseling regarding iNPH and
shunt surgery.
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METHODS

This study was performed with the same patient population used in the qualitative study
presented in the previous section. A detailed description of the patient sample and interview
data acquisition is described in the methods of that section. In summary, a total of 40
patients who were diagnosed with iNPH and underwent ventriculoperitoneal shunt surgery
were interviewed by telephone using the interview template shown in the Appendix.
Patient demographic data and information regarding patient preoperative course were
collected through retrospective review of the medical record. Patient self-reported
subjective outcomes were assessed in the interview by asking patients specifically if they
had any improvement with each of gait, cognitive, and urinary symptoms. Outcomes were
reported as improvement or no improvement. A total of 37 patients were deemed eligible
to be included in the final study population. Informed consent was obtained from all
participants in this study, and this study was approved by the Yale University Institutional
Review Board.

Patient imaging parameters were retrospectively evaluated by a board certified
neuroradiologist using the most recent brain CT or MRI scan prior to shunt surgery. The
Evans’ index was measured as the ratio of the maximum width of the frontal horns of the
lateral ventricles and the maximum internal diameter of the skull in the same axial image.
The temporal horn width was reported as the average of the left and right maximum
diameters of the temporal horns on axial images. The diameter of the third ventricle was
measured as the transverse diameter, taken at the center of the ventricle in the
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anteroposterior direction, on the axial image which demonstrated the widest diameter (29).
The callosal angle was measured as the angle between the left and right corpus callosum
on the coronal image through the posterior commissure and perpendicular to the
anteroposterior commissure plane (26). The callosal height was measured on the midline
sagittal image as the maximum orthogonal distance between the roof of the lateral ventricle
and the anteroposterior commissure plane. The thickness of the corpus callosum was
measured in the same line used to measure the callosal height.

The dilation of the Sylvian fissures was classified into three groups: narrow or normal,
mildly dilated, and severely dilated. This was done using the method described by
Hashimoto et al. (11). Compression of the medial high convexity was graded by means of
a method modified from Narita et al. and using the following ordinal scale: 0 = dilated or
normal, 1 = mild compression, and 2 = severe compression. This was evaluated on the four
uppermost contiguous transverse sections and on the three contiguous coronal sections on
and anterior to the posterior commissure (30). DESH was graded as present if compression
of the medial high convexity and dilation of the Sylvian fissures were both present. If
compression of the medial high convexity was graded as dilated or normal, or the dilation
of the Sylvian fissures was graded as narrow or normal, then DESH was graded as absent.
Compression of the peripheral high sulci was graded on the same images and with the same
ordinal scale used to grade compression of the medial high convexity. Focally dilated sulci,
as originally described by Holodny et al., were reported as present or absent (31).
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Deep white matter hyperintensities (DWMH) were graded on T2 fluid attenuation
inversion recovery (FLAIR) images using the method developed by Fazekas et al., and
reported with the following ordinal scale: 0 = no lesions, 1 = punctate foci, 2 = beginning
confluence of foci, and 3 = large confluent areas (32). Periventricular hyperintensities
(PVH) were graded on T2 FLAIR images using the method developed by Virhammar et
al. (29) which is modified from the method originally developed by Fazekas et al. (32) .
PVH were reported with the following ordinal scale: 0 = absent or normal “pencil-thin”
lining along the ventricular wall, 1 = increased, and 2 = irregular large symmetric
hyperintensities extending into the deep white matter, with extension from the ventricles
to the cortex in at least two locations.

The measured imaging features were analyzed as independent variables to identify any
possible associations with improvement in each of gait, cognitive, and urinary function.
The chi-square test and Student’s t-test were used to identify associations between imaging
features and postoperative outcome. Associations with a P value < .30 were analyzed using
univariate logistic regression to identify any predictive relationship. All statistical analyses
were performed using SAS software version 9.4 (Copyright  2013 SAS Institute Inc.).
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RESULTS

A total of 64 consecutive patients were eligible to participate, of which 40 volunteered to
partake in the study and were interviewed. Three patients were deemed ineligible for
inclusion after the interview due to removal of the shunt in the time between the initial
surgery and the interview. A total of 37 patients are included in the final analysis.

Patient characteristics including medication use and select comorbid conditions are
summarized in Table 3. The median age was 76 years (range 64 - 90). Cardiovascular
disease was present in 84% of patients, diabetes mellitus in 30%, and a history of stroke in
22%. Thirty-four (92%) patients had an MRI scan of the brain prior to shunt surgery, while
three (8%) had a CT scan.

Patient symptoms related to iNPH as well as postoperative outcomes are summarized in
Table 4. The median duration between shunt surgery and interview was 30 months (range
12 - 56). At the time of diagnosis of iNPH, gait disturbance was the most common symptom
and present in 100% of patients, followed by urinary incontinence in 84%, and cognitive
impairment in 76%. After shunt surgery, 84% of patients reported improvement in gait,
48% reported improvement in urinary incontinence, and 43% reported cognitive
improvement.

38
Table 3. Patient characteristics (n=37)
Characteristic

Number of Patients (%)

Age
Median
76 years
Range
64 - 90 years
Sex
Male
17 (46%)
Female
20 (54%)
Race
Caucasian
35 (95%)
African-American
1 (3%)
Asian
1 (3%)
Medications
Anti-hypertensive
28 (76%)
Lipid lowering
22 (59%)
Anti-platelet or anti-coagulation
18 (49%)
Anti-diabetic
11 (30%)
Anti-psychotic
7 (19%)
Anti-depressant
18 (49%)
Benzodiazepine
11 (30%)
A
Anti-Parkinson’s disease
4 (11%)
B
Cognition enhancing
6 (16%)
Comorbid cardiovascular disease
Any
31 (84%)
Hypertension
24 (65%)
Hyperlipidemia
19 (51%)
Coronary artery disease
8 (22%)
Comorbid neurological disease
Stroke
8 (22%)
Alzheimer’s disease
0 (0%)
Parkinson’s disease
4 (11%)
Other comorbid condition
Diabetes mellitus
11 (30%)
Imaging modality
MRI
34 (92%)
CT
3 (8%)
A includes carbidopa-levodopa and rasagiline
B includes rivastigmine, donepezil, and memantine
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Table 4. Patient preoperative symptoms and postoperative outcomes (n=37)
Characteristic
Preoperative symptoms
Gait disturbance
Cognitive impairment
Urinary incontinence
Duration of preoperative symptoms
≤ 1 year
> 1 year
Time between surgery and interview
Median
Range
Patient reported outcome at interview
Gait improvement
Cognitive improvement
Urinary improvement
Other interview information
Satisfaction with shunt surgery
Would recommend surgery to another patient
Caregiver participated in interview
A
B

Number of Patients (%)
37 (100%)
28 (76%)
31 (84%)
26 (70%)
11 (30%)
30 months
12 - 56 months
31 (84%)
12 (43%A)
15 (48%B)
31 (84%)
34 (92%)
13 (35%)

represents 12 out of 28 patients
represents 15 out of 31 patients

Comparisons of preoperative imaging features and patient-reported outcomes for gait are
shown in Table 5. The presence of focally dilated sulci was the only imaging feature
associated with gait outcome. Gait improvement after shunting was present more often in
patients without focally dilated sulci (95% vs. 71%, P = .04). Logistic regression analysis
showed that the presence of focally dilated sulci was a predictor of gait improvement (OR
0.13 [95% CI, 0.01-1.22]; P = .07).

Comparisons of preoperative imaging features and patient-reported outcomes for cognition
are shown in Table 6. Cognitive outcome was associated with Evans’ index, diameter of
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the third ventricle, height of the corpus callosum, and dilation of the Sylvian fissures.
Patients with cognitive improvement after shunting had a larger preoperative Evans’ index
(mean 0.41 vs. 0.36, P < .01), larger third ventricular diameter (mean 11.3 mm vs. 9.5 mm,
P = .05), and larger callosal height (mean 40 mm vs. 36 mm, P = .06). Logistic regression
analysis showed that Evans’ index was a predictor of cognitive improvement (OR 1.40
[95% CI, 1.08-1.81] using a scale of 0.01; P = .01), the diameter of the third ventricle was
a predictor of cognitive improvement (OR 1.57 [95% CI 0.99-2.49]; P = .06), and the
height of the corpus callosum was a predictor of cognitive improvement (OR 1.17 [95%
CI 0.99-1.40]; P = .07). Cognitive improvement was also present more often in patients
with severe dilation of the Sylvian fissures (83% severe vs. 29% mild vs. 40% normal, P
= .07). However, logistic regression analysis showed that severe dilation of the Sylvian
fissures was not a significant predictor of cognitive improvement (OR 7.50 [95% CI 0.46122.68]; P = .16). The callosal angle and the presence of focally dilated sulci were not
associated with cognitive improvement, but met the threshold of P < .30 to be evaluated
with logistic regression. Analysis showed that both callosal angle (OR 0.97 [95% CI 0.931.02]; P = .25) and focally dilated sulci (OR 0.39 [95% CI 0.08-1.84]; P = .23) were not
predictors of cognitive improvement.

Comparisons of preoperative imaging features and patient-reported outcomes for urinary
symptoms are shown in Table 7. No imaging feature was associated with urinary outcome.
When examined with logistic regression analysis, the presence of grade 2 PVH was not
found to be a predictor of urinary improvement (OR 3.50 [95% CI 0.15-84.69]; P = .44).
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Table 5. Comparison of patient imaging features and gait outcome (n=37)
Imaging Feature
Evans’ index
Temporal horn width (mm)
Diameter of the third ventricle (mm)
Height of corpus callosum (mm)
Thickness of corpus callosum (mm)
Angle of corpus callosum (degrees)
Dilation of the Sylvian fissures
Narrow or normal
Mild dilation
Severe dilation
Compression of the medial high
convexity
Grade 0
Grade 1
Grade 2
Compression of the peripheral high
sulci
Grade 0
Grade 1
Grade 2
Disproportionately enlarged
subarachnoid space
Present
Absent
Focal dilation of sulci
Present
Absent
Deep white matter hyperintensity
Grade 0
Grade 1
Grade 2
Grade 3
Periventricular hyperintensity
Grade 0
Grade 1
Grade 2
*P < .10, **P < .05, ***P < .01

Gait
Improvement
(n=31)
0.39
7.4
10.7
39 (n=30)
4.4 (n=30)
69 (n=30)

No Gait
Improvement
(n=6)
0.36
7.5
12.5
40
4.5
70

8 (89%)
17 (81%)
6 (86%)

1 (11%)
4 (19%)
1 (14%)

.85

3 (100%)
1 (50%)
27 (84%)

0 (0%)
1 (50%)
5 (16%)

.32

5 (71%)
13 (87%)
13 (87%)

2 (29%)
2 (13%)
2 (13%)

.62

22 (81%)
9 (90%)

5 (19%)
1 (10%)

.53

12 (71%)
19 (95%)

5 (29%)
1 (5%)

.04**

6 (100%)
11 (79%)
13 (87%)
1 (50%)

0 (0%)
3 (21%)
2 (13%)
1 (50%)

.36

2 (67%)
21 (88%)
8 (80%)

1 (33%)
3 (13%)
2 (20%)

.61

P Value
.48
.86
.54
.83
.84
.89
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Table 6. Comparison of patient imaging features and cognitive outcome (n=28)
Imaging Feature
Evans’ index
Temporal horn width (mm)
Diameter of the third ventricle (mm)
Height of corpus callosum (mm)
Thickness of corpus callosum (mm)
Angle of corpus callosum (degrees)
Dilation of the Sylvian fissures
Narrow or normal
Mild dilation
Severe dilation
Compression of the medial high
convexity
Grade 0
Grade 1
Grade 2
Compression of the peripheral high
sulci
Grade 0
Grade 1
Grade 2
Disproportionately enlarged
subarachnoid space
Present
Absent
Focal dilation of sulci
Present
Absent
Deep white matter hyperintensity
Grade 0
Grade 1
Grade 2
Grade 3
Periventricular hyperintensity
Grade 0
Grade 1
Grade 2
*P < .10, **P < .05, ***P < .01

Cognitive
Improvement
(n=12)
0.41
7.4
11.3
40
4.4
63

No Cognitive
Improvement
(n=16)
0.36
7.1
9.5
36 (n=15)
4.5 (n=15)
71 (n=15)

2 (40%)
5 (29%)
5 (83%)

3 (60%)
12 (71%)
1 (17%)

.07*

1 (33%)
0 (0%)
11 (46%)

2 (67%)
1 (100%)
13 (54%)

.62

1 (25%)
5 (38%)
6 (55%)

3 (75%)
8 (62%)
5 (45%)

.54

10 (45%)
2 (33%)

12 (55%)
4 (67%)

.59

4 (31%)
8 (53%)

9 (69%)
7 (47%)

.23

1 (20%)
6 (60%)
5 (42%)
0 (0%)

4 (80%)
4 (40%)
7 (58%)
1 (100%)

.39

1 (33%)
7 (39%)
3 (43%)

2 (67%)
11 (61%)
4 (57%)

.67

P Value
.002***
.65
.05*
.06*
.79
.26
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Table 7. Comparison of patient imaging features and urinary outcome (n=31)
Urinary
No Urinary
Imaging Feature
Improvement
Improvement
P Value
(n=15)
(n=16)
0.39
0.39
.63
Evans’ index
7.6
7.5
.89
Temporal horn width (mm)
11
11.3
.86
Diameter of the third ventricle (mm)
41 (n=14)
40
.75
Height of corpus callosum (mm)
4.4 (n=14)
4.4
.97
Thickness of corpus callosum (mm)
72 (n=14)
66
.46
Angle of corpus callosum (degrees)
Dilation of the Sylvian fissures
3 (33%)
6 (67%)
.44
Narrow or normal
8 (50%)
8 (50%)
Mild dilation
4 (67%)
2 (33%)
Severe dilation
Compression of the medial high
convexity
2 (67%)
1 (33%)
.80
Grade 0
1 (50%)
1 (50%)
Grade 1
12 (46%)
14 (54%)
Grade 2
Compression of the peripheral high
sulci
2 (33%)
4 (67%)
.70
Grade 0
6 (50%)
6 (50%)
Grade 1
7 (46%)
6 (54%)
Grade 2
Disproportionately enlarged
subarachnoid space
11 (52%)
10 (48%)
.52
Present
4 (40%)
6 (60%)
Absent
Focal dilation of sulci
6 (46%)
7 (54%)
.83
Present
9 (50%)
9 (50%)
Absent
Deep white matter hyperintensity
1 (20%)
4 (80%)
.33
Grade 0
5 (42%)
7 (58%)
Grade 1
8 (67%)
4 (33%)
Grade 2
1 (50%)
1 (50%)
Grade 3
Periventricular hyperintensity
1 (50%)
1 (50%)
.10
Grade 0
7 (35%)
13 (65%)
Grade 1
7 (78%)
2 (22%)
Grade 2
*P < .10, **P < .05, ***P < .01
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DISCUSSION

This study was undertaken to identify any association between preoperative imaging
features and long term patient-reported subjective outcomes following shunt surgery in
patients with iNPH. The preoperative prevalence of gait disturbance (100%), cognitive
impairment (76%) and urinary incontinence (84%) in this study is consistent with the
prevalence reported in the literature (2). The rates of gait improvement (84%), cognitive
improvement (43%), and urinary improvement (48%) in this study are consistent as well,
however there is a wide range of reported improvement in the literature.

A few imaging features were associated with outcome after shunting, and these
associations demonstrated a trend towards statistical significance. Patients with focally
dilated sulci were less likely to have gait improvement. Patients with a larger Evans’ index,
larger third ventricle, and larger callosal height were more likely to have cognitive
improvement. No imaging feature was associated with urinary outcome. The mechanism
behind this relationship between imaging and outcome after shunting is unclear. The major
finding from this study appears to be that patients who present with a more dilated
ventricular system have a greater chance to experience long term cognitive improvement.

The results of this study add to the sparse literature that is present regarding the relationship
between patient imaging and postoperative outcome in iNPH. The retrospective study by
Virhammar et al. identified the angle of the corpus callosum, width of the temporal horns
of the lateral ventricles, and DESH to all be associated with improvement after shunt
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surgery (29). The outcomes were measured using physician-reported objective outcome
scales at one year after shunt surgery. A smaller callosal angle, wider temporal horns, and
the presence of DESH, were predictors of improvement after shunting. Still, none of these
features could be used to exclude patients from surgery as 57% of patients with a callosal
angle > 90 degrees had improvement postoperatively, 64% of patients without DESH had
improvement, and 47% of patients with temporal horns smaller than 5 mm had
improvement. The retrospective study by Kojoukhova et al. examined numerous imaging
features including DESH, Sylvian fissures, focal dilation of sulci, temporal horn width,
Evans’ index, and callosal angle (28). However, no feature on imaging was associated with
outcome after shunt surgery. The outcome was measured using a subjective binary
measurement of improvement or no improvement observed and reported by a physician at
two to three months postoperatively. The present study differs from these previously
reported studies in that the outcomes in this study were measured at a later time, mostly
multiple years after shunt surgery. In addition, the outcomes were measured as patientreported subjective outcomes, and they were measured for each of the three major
symptoms separately.

Interestingly, in this study the presence of DESH was not associated with patient outcome.
This is in contrast to previously reported studies in the literature. DESH was first described
as a subset of iNPH based on the results from the Study of Idiopathic Normal Pressure
Hydrocephalus on Neurological Improvement (SINPHONI) trial (11). Since that time, the
significance of DESH has been increasingly studied, with a few studies investigating the
association between DESH and postoperative outcome. One single institution analysis of
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iNPH patients examined the association between DESH and response to shunting at one
year after surgery (33). Outcomes were reported as improvement or no improvement based
on a combination of objective physician-reported measurements and subjective patientreported perceptions. The presence of DESH was found to have a positive predictive value
of 77% and the absence of DESH was found to have a negative predictive value of 25%
when used to predict a response to shunting. The low negative predictive value seen in this
study would indicate that the absence DESH cannot be used to exclude patients from shunt
surgery. Another group of researchers developed a method to create a DESH score for each
patient using five imaging features: ventriculomegaly, dilated Sylvian fissures, tight high
convexity, acute callosal angle, and focal sulcal dilation (34). Outcomes were measured
using various scales including the modified Rankin scale, iNPH grading scale, Mini-Mental
State Examination, and Timed Up and Go test. For each outcome measure, patients who
demonstrated improvement at one year after shunt placement were found to have higher
DESH scores compared to patients with no improvement. Despite the results of these
studies, the use of DESH to predict outcome after shunt surgery remains limited.

The results of the present study taken in combination with the major studies reported in the
literature would suggest that any relationship between imaging features and outcome after
shunting in iNPH patients remains controversial, with different and conflicting results
reported by the different studies. As a result, it is difficult to translate any associations
between imaging and outcome into information that can be used to better counsel patients.
Therefore, the role of imaging in patient counseling remains limited until more robust data
and more consistent results can be produced.
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Limitations
This study represents a population of patients with iNPH treated at a single institution. The
variability in diagnostic criteria and criteria for shunt placement among different physicians
will limit any comparisons of these results to those across different institutions. In addition,
there is great variability in the measurement of patient outcomes in the literature. Outcome
after shunt surgery in this study was measured as a patient-reported subjective binary
outcome, and comparison of these results to other studies can be limited by differences in
outcome measurements. Patients were recruited retrospectively and voluntarily to track
their outcome after shunt surgery, which carries a possibility of associated selection bias.
Future prospective studies are needed to better examine the relationship between imaging
features and postoperative outcome in iNPH. Finally, all imaging parameters in this study
were measured by a single neuroradiologist. The methods used to measure imaging features
were kept as specific, objective, and reproducible as possible, however there always
remains the possibility of interobserver variation when analyzing imaging.
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CONCLUSIONS

In patients with iNPH, the presence of focally dilated sulci on preoperative imaging may
be a predictor of gait improvement after shunting. A larger Evans’ index, larger third
ventricular diameter, and larger callosal height, may all be predictors of cognitive
improvement. No imaging feature was found to be predictive of urinary improvement. The
angle of the corpus callosum and the width of the temporal horns of the lateral ventricles
were both not associated with postoperative outcome. The presence of DESH was also not
associated with outcome after shunt surgery. The results of this study add to the discordant
results produced by the other major studies in the literature that examine the controversial
relationship between imaging and outcome after shunting in iNPH. It remains difficult to
utilize any associations between imaging features and outcome in the counseling of patients
with iNPH. The role of imaging in patient counseling remains limited until more robust
data and more consistent results can be produced.
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CONCLUSIONS
It is very difficult to counsel patients who are suspected to have iNPH. There are numerous
diagnostic criteria for iNPH, many possible clinical presentations, and great variability
among physicians who treat iNPH patients. It is also difficult to predict which patients will
improve and the extent of improvement that will be seen after shunting. In addition, there
are a wide variety of methods used to measure outcomes after shunt surgery. This two part
study was conducted in order to identify ways by which physicians could better counsel
patients with iNPH.

The first study involved a qualitative analysis of patients with iNPH who had undergone
shunt surgery and lived with their shunt for at least one year. Numerous themes emerged
from the thoughts and experiences shared by the patients. Patients often have a long and
difficult clinical course prior to receiving a diagnosis of iNPH. Patients are also desperate
to gain functional independence and mobility. Their frustration and desperation have a
great influence on their decision-making process. There is a willingness among patients to
take a chance with shunt surgery despite the inability of the surgeon to predict the outcome.
Patients also have numerous comorbid conditions that make it difficult to assess the
progression of their iNPH or any response to CSF shunting. Finally, the family and
caregivers of patients need to be included in patient counseling due to the immense
influence they wield over patients’ clinical course and motivations. These themes can be
incorporated into physician practice to improve patient counseling.
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The second study involved a comparison of preoperative brain imaging features and long
term patient-reported subjective outcome after shunt surgery in patients with iNPH. A few
imaging features were identified as possible predictors of postoperative improvement. The
presence of focally dilated sulci may be a predictor of gait improvement. A larger Evans’
index, larger third ventricular diameter, and larger callosal height, may all be predictors of
cognitive improvement. No imaging feature was predictive of urinary improvement. These
results are discordant with other major published studies that examine the association
between imaging and outcome, and which themselves produce conflicting results. The
utility of imaging parameters to predict outcome after shunting remains too controversial
to be included in patient counseling until more consistent results can be produced.
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APPENDIX
Final version of the semi-structured patient interview template.
Preoperative Experiences
Please describe how you were doing prior to neurosurgery and the events that lead you to
see a neurosurgeon.
How did you make the decision whether or not to have shunt neurosurgery? What factors
did you consider?
What did you hope to gain from the surgery?
Was there any anxiety surrounding the surgery and what factors were responsible?
Postoperative Outcomes
What was the most significant benefit that you experienced after shunt surgery?
Has your ability to walk improved after shunt surgery? Describe how you feel it has
improved.
Has your ability to clearly think improved after shunt surgery? Describe how you feel it
has improved.
Have your urinary symptoms improved after shunt surgery? Describe how you feel they
have improved.
Patient Reflections
Are you satisfied with your decision to have shunt surgery? Are you satisfied with the
outcome after surgery? Please explain.
What were some things the neurosurgeon did well or did not do well in your interactions?
Is there anything during the course of your illness and treatment that you would have done
differently?
What have been the most difficult things for you throughout the course of your illness?
How would you counsel another patient with normal pressure hydrocephalus? Would you
recommend shunt surgery? What things would you discuss with them?
Other than what the doctors told you, did you use any outside resources or information?

